Another case-control study conducted in Korea reported that a genotype that yields high IL10 production was associated with an increased risk of gastric cancer only within a low soybean intake group, suggesting that the anti-inflammatory effects of soy may counterbalance the pro-carcinogenic effects of the IL10 genetic variants [36]. The gene discussed is IL10; the disease is gastric cancer.